MARKET

DXCM

DXCM

DexCom
NASDAQ

Real-time Quotes | Nasdaq Last Sale

330.11
+4.71
+1.45%
After Hours: 330.11 0 0.00% 17:03 05/18 EDT
OPEN
329.99
PREV CLOSE
325.40
HIGH
337.48
LOW
328.87
VOLUME
835.04K
TURNOVER
--
52 WEEK HIGH
456.23
52 WEEK LOW
305.63
MARKET CAP
31.92B
P/E (TTM)
63.66
1D
5D
1M
3M
1Y
5Y
DexCom Inc. stock outperforms market on strong trading day
Shares of DexCom Inc. rallied 1.45% to $330.11 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...
marketwatch.com · 5h ago
Henderson Group Plc Buys Ferguson PLC, Uber Technologies Inc, DexCom Inc, Sells Salesforce. ...
GuruFocus News · 1d ago
Sands Capital Management Buys Shopify Inc, Snowflake Inc, Taiwan Semiconductor Manufacturing ...
GuruFocus News · 1d ago
DexCom Inc. stock rises Friday, outperforms market
Shares of DexCom Inc. rose 2.87% to $333.25 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...
marketwatch.com · 4d ago
DexCom, Inc. (NASDAQ:DXCM) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
DexCom (NASDAQ:DXCM) has had a rough three months with its share price down 21%. However, a closer look at its sound...
Simply Wall St. · 4d ago
Hudson Canyon Investment Counselors Llc Buys Abbott Laboratories, Digital Realty Trust Inc, ...
GuruFocus News · 6d ago
Peregrine Capital Management Llc Buys DocuSign Inc, Unity Software Inc, H&R Block Inc, ...
GuruFocus News · 6d ago
DexCom Inc. stock outperforms competitors on strong trading day
Shares of DexCom Inc. advanced 1.55% to $348.00 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...
marketwatch.com · 05/11 20:50
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DXCM. Analyze the recent business situations of DexCom through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DXCM stock price target is 474.21 with a high estimate of 540.00 and a low estimate of 364.00.
EPS
Institutional Holdings
Institutions: 922
Institutional Holdings: 101.01M
% Owned: 104.45%
Shares Outstanding: 96.71M
TypeInstitutionsShares
Increased
265
6.28M
New
81
1.41M
Decreased
220
5.95M
Sold Out
80
683.38K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.39%
Healthcare Equipment & Supplies
+0.35%
Key Executives
Chairman/President/Chief Executive Officer/Director
Kevin Sayer
Chief Financial Officer/Executive Vice President
Jereme Sylvain
Chief Operating Officer
Quentin Blackford
Executive Vice President/Chief Technology Officer
Jake Leach
Chief Human Resource Officer/Executive Vice President
Sadie Stern
Executive Vice President/Chief Technology Officer
Jacob Leach
Executive Vice President
Donald Abbey
Executive Vice President
Andrew Balo
Executive Vice President
Paul Flynn
Executive Vice President
Patrick Murphy
Executive Vice President
Chad Patterson
Executive Vice President
Barry Regan
Senior Vice President/Chief Risk Officer
Sumi Shrishrimal
Senior Vice President
Shelly Selvaraj
General Manager
Steven Pacelli
Lead Director/Independent Director
Mark Foletta
Independent Director
Steven Altman
Independent Director
Nicholas Augustinos
Independent Director
Richard Collins
Independent Director
Karen Dahut
Independent Director
Bridgette Heller
Independent Director
Barbara Kahn
Independent Director
Kyle Malady
Independent Director
Jay Skyler
Independent Director
Eric Topol
No Data
  • All
  • Financials
  • Insiders
More
About DXCM
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.

Webull offers kinds of DexCom, Inc. stock information, including NASDAQ:DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.